Ben Zhong Tang Selected Research

Photosensitizing Agents (Photosensitizers)

5/2022	A cell membrane-targeting AIE photosensitizer as a necroptosis inducer for boosting cancer theranostics.
5/2022	AIE-Active Photosensitizers: Manipulation of Reactive Oxygen Species Generation and Applications in Photodynamic Therapy.
5/2022	Organic photosensitizers for antimicrobial phototherapy.
1/2022	Effective Therapy of Drug-Resistant Bacterial Infection by Killing Planktonic Bacteria and Destructing Biofilms with Cationic Photosensitizer Based on Phosphindole Oxide.
1/2022	Cationization-Enhanced Type I and Type II ROS Generation for Photodynamic Treatment of Drug-Resistant Bacteria.
1/2022	Biomimetic Nanoplatform Loading Type I Aggregation-Induced Emission Photosensitizer and Glutamine Blockade to Regulate Nutrient Partitioning for Enhancing Antitumor Immunotherapy.
1/2022	Three-Pronged Attack by Hybrid Nanoplatform Involving MXenes, Upconversion Nanoparticle and Aggregation-Induced Emission Photosensitizer for Potent Cancer Theranostics.
12/2021	Trojan Horse-Like Nano-AIE Aggregates Based on Homologous Targeting Strategy and Their Photodynamic Therapy in Anticancer Application.
10/2021	Triple-Jump Photodynamic Theranostics: MnO2 Combined Upconversion Nanoplatforms Involving a Type-I Photosensitizer with Aggregation-Induced Emission Characteristics for Potent Cancer Treatment.
1/2021	Molecular Engineering of High-Performance Aggregation-Induced Emission Photosensitizers to Boost Cancer Theranostics Mediated by Acid-Triggered Nucleus-Targeted Nanovectors.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ben Zhong Tang Research Topics

Disease

118	Neoplasms (Cancer) 05/2022 - 06/2011
9	Infections 05/2022 - 01/2019
7	Hypoxia (Hypoxemia) 01/2022 - 01/2020
5	Phototoxic Dermatitis (Phototoxicity) 01/2022 - 09/2015
4	Photosensitivity Disorders (Photodermatitis) 05/2022 - 12/2019
4	Bacterial Infections (Bacterial Infection) 01/2022 - 01/2020
4	Inflammation (Inflammations) 01/2022 - 09/2016
4	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2013
4	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 07/2015
3	Colonic Neoplasms (Colon Cancer) 05/2022 - 01/2020
3	Residual Neoplasm 06/2021 - 10/2018
2	Communicable Diseases (Infectious Diseases) 05/2022 - 01/2021
2	Necrosis 02/2022 - 03/2019
2	Glioblastoma (Glioblastoma Multiforme) 02/2022 - 01/2014
2	Glioma (Gliomas) 02/2022 - 01/2020
2	Keratitis 12/2021 - 01/2021
2	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2021 - 07/2014
2	Ovarian Neoplasms (Ovarian Cancer) 11/2020 - 01/2020
2	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 10/2016
2	Fatigue 11/2018 - 11/2017
2	Kidney Diseases (Kidney Disease) 01/2018 - 01/2017
2	Weight Loss (Weight Reduction) 09/2017 - 03/2017
2	Breast Neoplasms (Breast Cancer) 07/2016 - 07/2015
1	Rupture 05/2022
1	Wounds and Injuries (Trauma) 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Persistent Infection 01/2022
1	Starvation 01/2022

Drug/Important Bio-Agent (IBA)

34	1-phenyl-3,3-dimethyltriazene (PDT)IBA 05/2022 - 12/2015
28	Photosensitizing Agents (Photosensitizers)IBA 05/2022 - 02/2015
17	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2022 - 12/2015
14	Pharmaceutical PreparationsIBA 01/2022 - 02/2014
9	PolymersIBA 01/2022 - 03/2017
7	Peptides (Polypeptides)IBA 02/2022 - 02/2014
7	Fluorescent Dyes (Fluorescent Probes)IBA 12/2020 - 01/2013
6	Anti-Bacterial Agents (Antibiotics)IBA 05/2022 - 01/2021
6	Therapeutic UsesIBA 01/2022 - 06/2013
5	Singlet OxygenIBA 01/2022 - 04/2017
5	Proteins (Proteins, Gene)FDA Link 07/2020 - 06/2011
5	IntegrinsIBA 07/2015 - 06/2012
4	Coloring Agents (Dyes)IBA 01/2022 - 06/2017
4	LigandsIBA 06/2021 - 09/2018
4	Small Interfering RNA (siRNA)IBA 03/2021 - 10/2019
4	Biomarkers (Surrogate Marker)IBA 03/2021 - 07/2015
4	Biological ProductsIBA 10/2020 - 02/2014
3	Indicators and Reagents (Reagents)IBA 03/2021 - 10/2019
3	EstersIBA 01/2020 - 03/2018
3	aspartic acid glycine arginineIBA 01/2019 - 03/2013
3	Folic Acid (Vitamin M)FDA LinkGeneric 07/2017 - 12/2012
2	OxidesIBA 01/2022 - 03/2021
2	AlbuminsIBA 01/2022 - 01/2017
2	PolyelectrolytesIBA 01/2022 - 11/2012
2	Oxygen (Dioxygen)IBA 01/2022 - 01/2021
2	Glutamine (L-Glutamine)FDA Link 01/2022 - 01/2022
2	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2022 - 12/2018
2	B7-H1 AntigenIBA 01/2022 - 06/2021
2	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 07/2020
2	AntigensIBA 08/2021 - 06/2021
2	Hydroxyl RadicalIBA 01/2021 - 12/2020
2	MicellesIBA 01/2021 - 10/2019
2	AcidsIBA 01/2021 - 01/2021
2	Cetuximab (Erbitux)FDA Link 10/2017 - 08/2016
2	ErbB Receptors (EGF Receptor)IBA 10/2017 - 08/2016
2	SolventsIBA 09/2017 - 03/2017
2	Paclitaxel (Taxol)FDA LinkGeneric 04/2017 - 03/2017
2	EnzymesIBA 02/2015 - 02/2014
2	ProdrugsIBA 10/2014 - 02/2014
1	DNA (Deoxyribonucleic Acid)IBA 05/2022
1	Acetaminophen (Paracetamol)FDA LinkGeneric 02/2022
1	Apolipoproteins E (ApoE)IBA 02/2022
1	ApolipoproteinsIBA 02/2022
1	SolutionsIBA 01/2022
1	Coordination ComplexesIBA 01/2022
1	Bacterial ToxinsIBA 01/2022
1	NitrogenIBA 01/2022
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2022
1	PropaneIBA 01/2022
1	Liposomes (Liposome)IBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	2,5-dichloro-4-bromophenol (B 2)IBA 01/2022
1	PyrrolesIBA 01/2022
1	ThiadiazolesIBA 01/2022
1	ThiophenesIBA 01/2022
1	Proton Pump InhibitorsIBA 01/2022
1	SulfurIBA 01/2022
1	Adenosine Triphosphate (ATP)IBA 01/2022
1	Oxidoreductases (Dehydrogenase)IBA 01/2022
1	CopperIBA 01/2022

Therapy/Procedure

45	Therapeutics 05/2022 - 10/2012
41	Precision Medicine 05/2022 - 02/2014
36	Photochemotherapy (Photodynamic Therapy) 05/2022 - 02/2015
8	Lasers (Laser) 05/2022 - 11/2012
8	Photothermal Therapy 01/2022 - 01/2017
6	Drug Therapy (Chemotherapy) 01/2022 - 01/2019
4	Phototherapy (Light Therapy) 05/2022 - 03/2019
3	Immunotherapy 01/2022 - 06/2021
2	Optical Fibers 05/2022 - 01/2021
2	Intravenous Injections 01/2021 - 03/2019
2	Radiotherapy 10/2019 - 06/2019
1	Neoadjuvant Therapy 01/2022